Astrac-S 375mg Injection
By Astrac-S
Rx
1 Powder for Injection in a Vial

Composition
Ceftriaxone(250mg) + Sulbactam(125mg)

Manufacturer - Asterisk Laboratories India Pvt Ltd
S.C.O 867 Basement N.A.C Manimajra, Chandigarh-160101

Expires on or after
July, 2026

liver
Astrac-S 375mg Injection should be used with caution in individuals with severe liver disease. If you have severe liver issues, it may be necessary to adjust the dosage of Astrac-S 375mg Injection. Remember to consult your healthcare provider before use. However, for those with mild to moderate liver disease, adjusting the dose of Astrac-S 375mg Injection is not usually required. Take note of your liver health status and always seek guidance from your doctor regarding the appropriate use of this medication.

kidney
Limited information exists about the safety of using Astrac-S 375mg Injection in individuals with kidney problems. Consulting a doctor is advised.

alcohol
It is stated that consuming alcohol with Astrac-S 375mg Injection does not lead to harmful side effects.

driving
When taking Astrac-S 375mg Injection, beware that it may reduce alertness, impair vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Astrac-S 375mg Injection is generally safe to use during pregnancy based on animal studies with low adverse effects. Limited human studies are available.

breastfeeding
Exercise caution when using Astrac-S 375mg Injection while breastfeeding. It is advisable to pause breastfeeding until the mother's treatment is finished and the drug is no longer in her system.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹49
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025
